| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 395.00K | 108.00K | 300.00K | 0.00 | 500.00K | 0.00 |
| Gross Profit | 244.00K | 37.00K | 27.00K | -2.00K | 500.00K | -5.00K |
| EBITDA | -988.00K | -1.02M | -782.00K | -1.08M | -439.00K | -1.30M |
| Net Income | -40.00K | 40.00K | -726.00K | -1.08M | -888.00K | -1.43M |
Balance Sheet | ||||||
| Total Assets | 988.00K | 1.63M | 2.48M | 2.99M | 3.61M | 136.00K |
| Cash, Cash Equivalents and Short-Term Investments | 361.00K | 1.26M | 2.28M | 2.85M | 3.56M | 108.00K |
| Total Debt | 144.00K | 169.00K | 412.00K | 305.00K | 297.00K | 1.66M |
| Total Liabilities | 766.00K | 776.00K | 671.00K | 566.00K | 508.00K | 1.99M |
| Stockholders Equity | 222.00K | 851.00K | 1.81M | 2.43M | 3.10M | -1.85M |
Cash Flow | ||||||
| Free Cash Flow | -1.07M | -995.00K | -566.00K | -707.00K | -234.00K | -849.00K |
| Operating Cash Flow | -920.00K | -918.00K | -548.00K | -672.00K | -234.00K | -849.00K |
| Investing Cash Flow | -153.00K | -77.00K | -18.00K | -35.00K | 0.00 | 0.00 |
| Financing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 3.69M | 931.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | $54.32M | -84.10 | -2.26% | ― | -13.52% | -103.42% | |
49 Neutral | $18.43M | -16.51 | -121.21% | ― | ― | ― | |
49 Neutral | $24.14M | >-0.01 | ― | ― | 95.38% | 45.87% | |
48 Neutral | $15.81M | -11.19 | -11.98% | ― | -6.77% | -192.82% | |
46 Neutral | $139.69M | -1.61 | -142.81% | ― | -30.18% | 80.43% | |
41 Neutral | $6.73M | -0.03 | ― | ― | -63.81% | 81.84% |
On December 30, 2025, Duke Robotics entered into definitive securities purchase agreements with a group of accredited investors, including long-time backers, for a private placement that raised gross proceeds of $750,000, as disclosed in a January 5, 2026 announcement. The financing, structured in units priced at $0.36 comprising one common share and a warrant exercisable at $0.65 until November 30, 2026, was completed at a premium to market and is expected to bolster the company’s balance sheet and support near-term operational and commercialization efforts, while providing price protection to investors and signaling continued confidence from existing shareholders in the company’s growth plans.